USPTO serial 85909662
ZOË SCRIPTS
Reviewed by CopyMark Law Group
Reg. 4669519Status 710
- Filing date
- Status date
- Registration date
- Jan 13, 2015
- Examiner
- PINO, BRIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ZOË SCRIPTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brittany J. Maxey
BRITTANY J. MAXEY MAXEY LAW OFFICES, PLLC100 Second Avenue SouthSuite 401 NorthSt. Petersburg, FL 33701Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated ointments for the prevention and treatment of sunburn | SECTION 8 - CANCELLED | May 1, 2012 |
| 005 | Chemical preparations for pharmaceutical or medical purposes, namely, for reducing pain, supporting and improving men's health in the nature of treating infertility, treating impotence, treating benign prostatic hyperplasia (BPH), treating parathyroid disease, reducing risk of kidney stones, reducing risk of prostate cancer, treating vitamin and mineral deficiencies, treating low testosterone levels, reducing risk of high cholesterol and hypertension, treating high cholesterol and hypertension, supporting and improving women's health in the nature of reducing symptoms and treating conditions associated with menopause, reducing symptoms and treating conditions associated with menstruation, treating ailments that occur during and after pregnancy, hormone replacement therapies to promote the health and wellbeing of the female reproductive system, maintenance of healthy urinary tracts, treating vitamin and mineral deficiencies, treating low estrogen, treating osteoporosis, reducing the risk of breast cancer, treating ophthalmic conditions and diseases, treating gastroesophageal reflux disease (GERD), treating dermatological conditions and diseases, treating thyroid dysfunction, and treating infections; Pharmaceutical preparations for the prevention and treatment of ophthalmic conditions and diseases, gastroesophageal reflux disease (GERD), dermatological conditions and diseases, thyroid dysfunction, and infections; Anti-infective preparations; Antiviral preparations; Antibiotic preparations; Antifungal preparations pharmaceutical preparations for skin care; Pain, anti-itch, anti-fungal and antibiotic ointments; Men's health ointments for use in treating infertility, treating impotence, treating benign prostatic hyperplasia (BPH), treating parathyroid disease, reducing risk of kidney stones, reducing risk of prostate cancer, treating vitamin and mineral deficiencies, treating low testosterone levels, reducing risk of high cholesterol and hypertension, treating high cholesterol and hypertension; Women's health ointments for use in reducing symptoms and treating conditions associated with menopause, reducing symptoms and treating conditions associated with menstruation, treating ailments that occur during and after pregnancy, hormone replacement therapies to promote the health and wellbeing of the female reproductive system, maintenance of healthy urinary tracts, treating vitamin and mineral deficiencies, treating low estrogen, treating osteoporosis, reducing the risk of breast cancer; Topical pain medications, gels, rubs and creams; Analgesic formulations by physician prescription; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals | SECTION 8 - CANCELLED | May 1, 2012 |
| 035 | Mail order pharmacy services | SECTION 8 - CANCELLED | May 1, 2012 |
| 040 | Custom manufacture of pharmaceuticals by pharmaceutical compounders | SECTION 8 - CANCELLED | May 1, 2012 |
| 044 | Pharmaceutical compounding services; Physician compounding services | SECTION 8 - CANCELLED | May 1, 2012 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RS Compounding, LLC
- Other trademarks owned by RS Compounding, LLC
- Other trademarks owned by RS Compounding, LLC
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 044
- Similar marks named ZOË SCRIPTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 13, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 6, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 28, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 17, 2014 | UNDR | UNDELIVERABLE MAIL - CORRESP. REMAILED | — |
| Oct 8, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 22, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 15, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 13, 2014 | RDX2 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED MAILED | — |
| Jun 13, 2014 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| May 27, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 27, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 20, 2014 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 20, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 11, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 11, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 28, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 19, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 13, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2013 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2013 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Apr 26, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |